Valuation: RushNet, Inc.

Market Cap 1.23Cr 1.08Cr 1Cr 92.17L 1.73Cr 117.62Cr 1.75Cr 12Cr 4.66Cr 58Cr 4.6Cr 4.5Cr 200.73Cr P/E 2020
13.3x
P/E 2021 55x
Enterprise Value 1.82Cr 1.6Cr 1.49Cr 1.37Cr 2.57Cr 174.47Cr 2.6Cr 18Cr 6.91Cr 86Cr 6.83Cr 6.68Cr 297.77Cr EV / Sales 2020
2.75x
EV / Sales 2021 1.77x
Free-Float
100%
Yield 2020 *
-
Yield 2021 -
1 month 0
Extreme 0
0
Current year 0
Extreme 0
0
1 year 0
Extreme 0
0
3 years 0
Extreme 0
0
5 years 0
Extreme 0
0.01
10 years 0
Extreme 0
0.02
Manager TitleAgeSince
Chief Executive Officer - 04/03/2024
Chief Operating Officer 45 02/08/2021
Director TitleAgeSince
Chairman - 04/03/2024
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - -83.33% 8.77T
+0.91%+11.07%-16.08%+55.91% 641.16Cr
+1.31%+0.81%-7.06%-8.18% 478.68Cr
+1.64%-11.96%-15.25% - 212.28Cr
-1.09%-2.79%+61.56%+1,928.54% 161.75Cr
+0.62%+3.37%-7.05%-31.32% 144.85Cr
-0.09%+0.62%-6.50%-38.84% 132.05Cr
-2.22%-3.52%+197.16% - 106.32Cr
+1.08%-0.99%-26.85%-31.46% 78Cr
0.00%+1.25%-3.40%-13.82% 63Cr
Average +0.23%-0.56%+19.61%+222.19% 201.79Cr
Weighted average by Cap. +0.66%+0.98%+4.86%+194.73%

Financials

2020 2021
Net sales 43.88L 38.57L 35.91L 32.98L 61.92L 42Cr 62.74L 4.27Cr 1.67Cr 21Cr 1.65Cr 1.61Cr 72Cr 58.97L 51.84L 48.25L 44.32L 83.22L 57Cr 84.31L 5.74Cr 2.24Cr 28Cr 2.21Cr 2.17Cr 97Cr
Net income 10L 9L 8L 7L 13.98L 9.5Cr 14.17L 96.37L 37.64L 4.69Cr 37.19L 36.39L 16Cr 2L 1L 1L 1L 2L 1.57Cr 2L 15.91L 6L 77.45L 6L 6L 2.68Cr
Net Debt 58.7L 51.6L 48.04L 44.11L 82.84L 56Cr 83.93L 5.71Cr 2.23Cr 28Cr 2.2Cr 2.16Cr 96Cr 59.29L 52.12L 48.52L 44.56L 83.67L 57Cr 84.77L 5.77Cr 2.25Cr 28Cr 2.23Cr 2.18Cr 97Cr
Logo RushNet, Inc.
RushNet, Inc. provides management and insurance billing services to clinical laboratories and laboratory services. The Company’s subsidiaries include Chattahoochee Physicians Laboratory Services, LLC, doing business as HeliosDx, and Grandeza Healthcare Consultants, LLC (Grandeza). HeliosDx offers urine drug testing, allergy droplet cards, oral fluids, Polymerase Chain Reaction (PCR) for nails, wounds, respiratory pathogens, sexually transmitted infections, gastrointestinal issues, urinary tract infections, and pharmacogenomics testing through lab partners. Grandeza provides management and insurance billing services to clinical reference laboratories.
Employees
18
Date Price Change Volume
24/26/24 $0.000001 -.--% 30,000
23/26/23 $0.000001 -.--% 1,500
  1. Stock Market
  2. Stocks
  3. RSHN Stock